[Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)].
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation*; D001569:Benzodiazepines / Q000009:adverse effects; D015897:Comorbidity; D003631:Day Care, Medical; D005260:Female; D005858:Germany; D006760:Hospitalization; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000523:psychology / Q000534:rehabilitation; D008875:Middle Aged; D009042:Motivation; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis* / Q000523:psychology; D010147:Pain Measurement / Q000706:statistics & numerical data; D011594:Psychometrics / Q000706:statistics & numerical data; D011619:Psychotropic Drugs / Q000009:adverse effects; D012680:Sensitivity and Specificity; D016540:Smoking Cessation / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000523:psychology; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D011795:Surveys and Questionnaires; D055815:Young Adult
D011619:Psychotropic Drugs; D001569:Benzodiazepines
Entwicklung und Validierung eines Instrumentes zur substanzunabhängigen Erfassung von Craving: Die Mannheimer Craving Scale (MaCS).